Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
The potential growth difference for the hydrolyzed collagen market between 2021 and 2026 is $541.45 million, according to a report from Technavio. The increasing adoption of hydrolyzed collagen-based supplements to improve joint conditions and support bone health is one of the major factors driving the growth of the market. Hydrolyzed collagen ...
read more
The Alzheimer’s Disease therapeutic market is projected to grow by $3.9B, accelerating at a CAGR of 8.76% from 2021 to 2026, with 37% of the growth originating in North America, according to a report from Technavio.
read more
Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for IPX203 for the treatment of Parkinson’s disease (PD). IPX203 is a novel, oral formulation of carbidopa/levodopa (CD/LD) extended-release capsules.
read more
Bristol Myers Squibb Canada (BMS) announced Health Canada's approval of CAMZYOSTM (mavacamten capsules) for the treatment of symptomatic obstructive hypertrophic cardiomyopathy (oHCM) of New York Heart Association (NYHA) Class II-III in adult patients.
read more
The global drug formulation market was valued at over $1.5T in 2021 and is expected to grow at a CAGR of 5.6% by 2032, according to a report by Future Market Insights.
read more
The global fertility supplement market size is predicted to reach $3.52B by 2030, according to a new report by Grand View Research, expanding at a CAGR of 7.9% from 2022 to 2030.
read more
Upsher-Smith Laboratories announced that it has extended its line of Haloperidol Tablets, USP and is now offering unit dose packaging in 1 mg, 5 mg, and 10 mg strengths
read more
The compounding pharmacy market size is set to grow by $1.5B from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 2.15% during the forecast period, according to a report from Technavio.
read more
The cannabidiol (CBD) industry's rapid growth reflects the many needs this compound meets. However, regulatory and health issues related to its use remain unaddressed, according to a report by Research & Markets.
read more
Aphena Pharma Solutions Inc. announced that its $20M expansion and renovation, which began mid-2019 in Cookeville, Tennessee, is now complete.
read more
Ascletis Pharma announced that the Investigational New Drug (IND) application of ASC11, an oral inhibitor drug candidate targeting 3-chymotrypsin like protease (3CLpro) for COVID-19, has been filed to the U.S. Food and Drug Administration (FDA) after the Pre-IND consultation.
read more
The omega 3 supplements market is valued at $5.875B for 2020, growing at a CAGR of 7.15% reaching an anticipated market size of $9.5B by 2027. The market for omega-3 supplements is being driven by the growing number of people who have been diagnosed with heart disease.
read more
Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Vemlidy® (tenofovir alafenamide) 25 mg tablets as a once-daily treatment for chronic hepatitis B virus (HBV) infection in pediatric patients 12 years of age and older with compensated liver disease.
read more
The China pharmaceutical contract manufacturing market is projected to grow at a CAGR of around 12.1% from 2022 through 2028. The major factor that drives the growth of the market includes the major companies in the pharmaceutical contract manufacturing market are expanding their manufacturing capacity in China.
read more
Paratek Pharmaceuticals announces the commercial availability of U.S.-produced NUZYRA® (omadacycline) tablets. This milestone follows a successful technology transfer by Paratek and its tablet manufacturing partners in the United States and Europe.
read more